 NEW YORK, Feb. 17, 2021 GLOBE NEWSWIRE -- Royalty Pharma plc Nasdaq: RPRX today reported financial results for the fourth quarter of 2020 and introduced full-year 2021 guidance for Adjusted Cash Receipts1 a non-GAAP financial measure. 